Pharma Pricing Congress

Hot topics in pharma and orphan drugs

By Christina Poschen I attended this year’s Pharma Pricing and Market Access Conference in London with attendees across the pharmaceutical industry, payer and HTA bodies and patient representatives. While following the talks, panel discussions and roundtable debates, a few overarching key topics crystallised: –          Germany – AMNOG changes AMNOG, the German pharmaceutical law is regularly adapted to changes in the …

PRA whitepaper, sponsor and cro pharmacovigilance, alliances

Whitepaper: Sponsor & CRO Pharmacovigilance Alliances

Outsourcing pharmacovigilance activities is a standard business practice in a rapidly expanding market segment. In the past, outsourced safety services were limited due to concerns about confidentiality, data security and liability in cases of regulatory non-compliance, which are all still important considerations today. Because of the changing industrial and regulatory environment, sponsors are re-evaluating the advantages and disadvantages of outsourcing their pharmacovigilance obligations. With stricter …

Download: Biosimilar development, a CRO perspective

Download this presentation here > The World Biosimilar Congress  brings together pharma, biotech, academia and regulators and the wider service provider community to discuss the latest R&D, process, production, regulation and to-market strategies for biosimilar medicines. At the 2013 event, delegates were fortunate enough to hear from Dr John Patava, Director, Head Biosimilars Intelligence and Capabilities, Quintiles, who delivered the presentation ‘Biosimilar development, a CRO perspective‘. Download this presentation …

Download: A-Z of Clinical Trials

Clinical trials are currently undergoing a massive overhaul in how they are designed and executed. With the cost of clinical trials skyrocketing in the west, new innovations are providing researchers with the tools to improve data quality whilst reducing costs: Something that is especially important given drying up of the new substance pipelines across the pharmaceutical industry. In March 2014 …

Download: How to Choose a CRO: Success factors

Cecilia FrostegÃ¥rd-Sundquist, Head of Global Clinical Operations, Swedish Orphan Biovitrum gave a presentation at Clinical Outsourcing World Europe 2013 on How to choose a CRO – success factors for small companies to engage with both large and small CROs. Download the presentation and learn: Key success factors for selection of CRO What core competencies do you need to make sure …

Download: Clinical Outsourcing Best Practice: How procurement helps sponsors and CROs connect

  What is driving outsourcing within MD&D? Procurement? What do they do? Why does procurement involvement help?  Answers to these questions and more can be found in the presentation “How Procurement helps sponsors and CROs connect” given at Clinical Outsourcing World Europe 2013 by Brandon Cheal, R&D/Clinical Category Procurement, Johnson and Johnson. Download this presentation and learn about: J&J Landscape …

Strategic R&D Partnerships For Global Competitiveness

Pharma giants face immense challenges as old business models become obsolete, key drugs patents expire, and not to mention the large amounts of capital inlay into drug development. Concurrently, Biotechs struggle to keep up with the competition against these pharma giants. The great news is that pharma giants like Pfizer are now considering to partner Biotech companies to undertake the …

ClinActis Pte Ltd at the BioPharma Asia Convention 2012

ClinActis Pte Ltd will participate in the BioPharma Asia Convention 2012 which will take place in Singapore from March 19th to March 22nd, 2012. BioPharma Asia Convention 2012 brings together industry stakeholders across the entire biopharmaceutical value chain, from partnering to drug discovery, manufacturing, supply chain and clinical trials. This year, ClinActis Pte Ltd will be participating in the event. …

PRA Opens Office in Singapore, Centralized Operations to Enhance Regional Presence

New office will serve as PRA's central clinical operations location for the region, strengthening the quality and timeliness of our deliverables to sponsors. Contributed by PRA: PRA, a leading Clinical Research Organization, continues our expansion across the burgeoning Asia-Pacific region with the recent opening of an office in Singapore. The Singapore facility, conveniently located in the heart of the city-state, …